PNI-BASED STRESS MANAGEMENT IN EARLY BREAST CANCER
基于 PNI 的早期乳腺癌压力管理
基本信息
- 批准号:7454962
- 负责人:
- 金额:$ 55.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-09-21 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdjuvant ChemotherapyAttenuatedBehavior TherapyBehavioralBiologicalBiological MarkersBreastCaringChemotherapy-Oncologic ProcedureChronicClinical TrialsControl GroupsCoping SkillsDataDiagnostic Neoplasm StagingDiseaseDistressDoseEquationEventFatigueFrequenciesFutureGray unit of radiation doseGrowthHealthHealth StatusHydrocortisoneImmuneImmune System and Related DisordersImmune systemImmunosuppressionInterventionInterviewInvestigationLeucine EnkephalinLightLymphocyteLymphokine-Activated Killer CellsMalignant NeoplasmsMeasurementMeasuresMediationMediator of activation proteinMedicalMental DepressionMind-Body InterventionModelingNatural HistoryNatural Killer CellsNeurosecretory SystemsOperative Surgical ProceduresOutcomeOutcome StudyParticipantPatternPerformancePersonal SatisfactionPersonsPiperProcessProductionPsychological FactorsPsychoneuroimmunologyPsychosocial FactorPurposeQualitative MethodsQuality of lifeQuestionnairesRandomized Clinical TrialsRecurrenceReportingResearchResearch PersonnelSamplingScoreSocial Aspects of CancerSocial supportSpiritualityStandards of Weights and MeasuresStressStress and CopingStructureSymptomsTai JiTestingTheoretical modelTherapeutic immunosuppressionTimeTrainingTreatment ProtocolsWalkingWomanbasebeta-Endorphinbody-mindcancer recurrencecancer therapychemotherapycofactorcopingcytokinecytotoxiccytotoxicitydepressive symptomsdesignepidemiology studyexperiencehazardimmune functionimprovedinclusion criteriamalignant breast neoplasmnovelprogramspsychological distresspsychosocialsocialstress managementtumor progression
项目摘要
DESCRIPTION (provided by applicant): A growing body of research with persons having chronic and potentially fatal illnesses such as cancer indicates that a variety of complementary "mind-body" interventions, including strategies for stress management, can not only mitigate psychological distress and improve coping skills, but also can enhance immune function through neuroendocrine-immune system modulation. Psychoneuroimmunology (PNI), the theoretical framework within which this proposal is grounded, is concerned with the mechanisms of multidimensional psychobehavioral-neuroendocrine-immune system interactions, including the influence of psychosocial, spiritual, and behavioral factors on health outcomes. To date, the majority of psycho behavioral studies in persons with cancer have not examined PNI-based biological indicators. While PNI-based research among persons with cancer is clearly indicated, the multiplicity and complexity of diseases and treatments render such research difficult, particularly in relation to the selection and measurement of appropriate biological markers. The customary immunological measures of lymphocyte proliferative function and natural killer cell cytotoxicity need to be augmented by investigations that may elucidate underlying mechanisms of immunosuppression, using measures such as patterns of cellular cytokine production. Additionally, the timing of such measures in relation to disease and treatment parameters must be carefully controlled and evaluated. This proposal directly addresses these issues by precisely controlling sample inclusion criteria, including medical treatment protocols, and by measuring multiple psycho behavioral, neuroendocrine, immunological, and health status variables over time. The proposed study is a randomized clinical trial involving 240 women receiving adjuvant chemotherapy for early breast cancer. The study is designed to test two psycho behavioral interventions, which we view holistically as mind-body-spirit interventions, and to evaluate multiple biological markers that may shed light on cancer- and treatment-specific mechanisms. The overarching hypothesis is that both tai chi training and spiritual growth group interventions will reduce perceived stress, enhance coping patterns, normalize levels of stress-related neuroendocrine mediators, attenuate immunosuppression, and enhance the adaptational outcomes of psychosocial functioning, quality of life, and physical health.
描述(由申请人提供):越来越多的对患有慢性和潜在致命疾病(如癌症)的人的研究表明,各种补充性的“身心”干预,包括压力管理策略,不仅可以减轻心理困扰,提高应对技能,还可以通过神经内分泌-免疫系统调节增强免疫功能。心理神经免疫学(PNI)是这一建议所依据的理论框架,它关注的是多维心理行为-神经内分泌-免疫系统相互作用的机制,包括心理社会、精神和行为因素对健康结果的影响。迄今为止,大多数癌症患者的心理行为研究尚未检测基于pni的生物指标。虽然明确指出了在癌症患者中进行基于pni的研究,但疾病和治疗的多样性和复杂性使这种研究变得困难,特别是在选择和测量适当的生物标记物方面。淋巴细胞增殖功能和自然杀伤细胞细胞毒性的习惯免疫测量需要通过研究来阐明免疫抑制的潜在机制,如使用细胞细胞因子产生的模式。此外,必须仔细控制和评估与疾病和治疗参数有关的此类措施的时机。该提案通过精确控制样本纳入标准,包括医疗方案,并通过测量多种心理行为,神经内分泌,免疫学和健康状态变量,直接解决了这些问题。该研究是一项随机临床试验,涉及240名接受早期乳腺癌辅助化疗的妇女。该研究旨在测试两种心理行为干预,我们将其整体视为身心精神干预,并评估多种生物标记,这些标记可能会揭示癌症和治疗特异性机制。总体假设是,太极训练和精神成长小组干预都可以减少感知压力,增强应对模式,使压力相关的神经内分泌介质水平正常化,减轻免疫抑制,并增强心理社会功能,生活质量和身体健康的适应性结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nancy L McCain其他文献
Nancy L McCain的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nancy L McCain', 18)}}的其他基金
PNI-BASED STRESS MANAGEMENT IN EARLY BREAST CANCER
基于 PNI 的早期乳腺癌压力管理
- 批准号:
8166537 - 财政年份:2009
- 资助金额:
$ 55.13万 - 项目类别:
PNI-BASED STRESS MANAGEMENT IN EARLY BREAST CANCER
基于 PNI 的早期乳腺癌压力管理
- 批准号:
7950863 - 财政年份:2008
- 资助金额:
$ 55.13万 - 项目类别:
Feasibility of a Mindful Touch and Massage Intervention
正念触摸和按摩干预的可行性
- 批准号:
7563643 - 财政年份:2007
- 资助金额:
$ 55.13万 - 项目类别:
Physical Health, Depressive Symptoms, Happiness, and Maternal Competence
身体健康、抑郁症状、幸福感和母亲能力
- 批准号:
7563651 - 财政年份:2007
- 资助金额:
$ 55.13万 - 项目类别:
PNI-BASED STRESS MANAGEMENT IN EARLY BREAST CANCER
基于 PNI 的早期乳腺癌压力管理
- 批准号:
7717033 - 财政年份:2007
- 资助金额:
$ 55.13万 - 项目类别:
PNI-BASED STRESS MANAGEMENT IN EARLY BREAST CANCER
基于 PNI 的早期乳腺癌压力管理
- 批准号:
7605026 - 财政年份:2006
- 资助金额:
$ 55.13万 - 项目类别:
ALTERNATIVE STRESS MANAGEMENT APPROACHES IN HIV DISEASE
HIV 疾病的替代压力管理方法
- 批准号:
7375122 - 财政年份:2005
- 资助金额:
$ 55.13万 - 项目类别:
PNI-BASED STRESS MANAGEMENT IN EARLY BREAST CANCER
基于 PNI 的早期乳腺癌压力管理
- 批准号:
7375172 - 财政年份:2005
- 资助金额:
$ 55.13万 - 项目类别:
PNI-BASED STRESS MANAGEMENT IN EARLY BREAST CANCER
基于 PNI 的早期乳腺癌压力管理
- 批准号:
6838838 - 财政年份:2004
- 资助金额:
$ 55.13万 - 项目类别:
BIOBEHAVIORAL RESEARCH IN CRITICAL HEALTH EXPERIENCES
关键健康经历的生物行为研究
- 批准号:
6793836 - 财政年份:2004
- 资助金额:
$ 55.13万 - 项目类别:
相似海外基金
3D Engineered Model of Microscopic Colorectal Cancer Liver Metastasis for Adjuvant Chemotherapy Screens
用于辅助化疗筛选的显微结直肠癌肝转移 3D 工程模型
- 批准号:
10556192 - 财政年份:2023
- 资助金额:
$ 55.13万 - 项目类别:
Developing Digital Pathology Biomarkers for Response to Neoadjuvant and Adjuvant Chemotherapy in Breast Cancer
开发数字病理学生物标志物以应对乳腺癌新辅助和辅助化疗
- 批准号:
10315227 - 财政年份:2021
- 资助金额:
$ 55.13万 - 项目类别:
Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Stage III Colorectal Cancer: A Multicentre Phase II/III Randomised Controlled Trial (DYNAMIC-III)
循环肿瘤 DNA 分析为 III 期结直肠癌辅助化疗提供信息:多中心 II/III 期随机对照试验 (DYNAMIC-III)
- 批准号:
443988 - 财政年份:2021
- 资助金额:
$ 55.13万 - 项目类别:
Operating Grants
Establishment of new selection system for adjuvant chemotherapy of colorectal cancer
结直肠癌辅助化疗新选择体系的建立
- 批准号:
20K09011 - 财政年份:2020
- 资助金额:
$ 55.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improved survival by Helicobacter pylori-modulated immunity in gastric cancer patients with adjuvant chemotherapy
幽门螺杆菌调节免疫力可改善接受辅助化疗的胃癌患者的生存率
- 批准号:
19K09130 - 财政年份:2019
- 资助金额:
$ 55.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A new strategy of adjuvant chemotherapy for lung cancer based on the expression of anti-aging gene Klotho
基于抗衰老基因Klotho表达的肺癌辅助化疗新策略
- 批准号:
19K18225 - 财政年份:2019
- 资助金额:
$ 55.13万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel candidate factors predicting the effect of S-1 adjuvant chemotherapy of pancreatic cancer
预测胰腺癌S-1辅助化疗效果的新候选因素
- 批准号:
18K16337 - 财政年份:2018
- 资助金额:
$ 55.13万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Project 2-Metabolic Modulation of Myeloid-Derived Suppressor Cells to Increase Efficacy of Neo adjuvant Chemotherapy and Immunotherapy
项目2-骨髓源性抑制细胞的代谢调节以提高新辅助化疗和免疫疗法的疗效
- 批准号:
10005254 - 财政年份:2018
- 资助金额:
$ 55.13万 - 项目类别:
Radiogenomic tools for prediction of breast cancer neo-adjuvant chemotherapy response from pre-treatment MRI
通过治疗前 MRI 预测乳腺癌新辅助化疗反应的放射基因组学工具
- 批准号:
9763320 - 财政年份:2018
- 资助金额:
$ 55.13万 - 项目类别:
Analysis of the molecular mechanism for the prognostic biomarker of adjuvant chemotherapy
辅助化疗预后生物标志物的分子机制分析
- 批准号:
18K07341 - 财政年份:2018
- 资助金额:
$ 55.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)